Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics
About Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on healthcare systems. The technology analyzes dermoscopic images of skin lesions, captured using a smartphone with an approved dermatoscope, to triage cases into malignant, pre-malignant, or benign within milliseconds. This allows for the safe discharge of benign cases, reduces the need for unnecessary biopsies, and fast-tracks high-risk patients to specialists.
DERM is the world’s first autonomous AI legally authorized to make clinical decisions on skin cancer without human oversight, holding both a Class III CE mark under European regulations and a Class IIa UKCA mark. It has demonstrated a 99.8% accuracy rate in ruling out cancer, surpassing the typical 98.9% accuracy of dermatologists. The company primarily partners with national health systems and private insurers, with significant deployment across the UK’s National Health Service (NHS) where it has assessed over 170,000 patients and identified more than 15,500 cancers. This has helped some NHS partners avoid up to 95% of face-to-face urgent referral appointments.
Focus Areas
Business Intelligence
| Technology | cloud-native, AI as a Medical Device (AIaMD), deep learning algorithms, smartphone-based dermoscopic imaging |
What Physicians Need to Know
For physicians, Skin Analytics' DERM offers a tool to significantly reduce dermatology waiting times by autonomously triaging low-risk skin lesions, allowing specialists to focus on urgent cases. Fraunhofer AICOS's Derm.AI provides a mobile application to assist general practitioners in acquiring high-quality dermatological images and an AI-powered prioritization system for dermatologists, streamlining the referral process and aiding in early diagnosis. Both aim to enhance diagnostic pathways and improve patient outcomes through efficient AI-powered screening and decision support, while emphasizing that the final diagnosis remains with the specialist.
Fraunhofer AICOS's Derm.AI is designed for integration with existing teledermatology processes within national health services and e-referral systems. Their work also involves integrating known standards (e.g., FHIR, FiWARE) to support the development and deployment of ML/AI algorithms. Skin Analytics' DERM is deployed within NHS urgent suspected skin cancer pathways.
What the Web Says
Skin Analytics, in collaboration with Fraunhofer AICOS, has developed an AI-powered tool called DERM for early skin cancer detection. This tool has received positive attention for its high accuracy and efficiency in assessing potential skin cancers from smartphone photographs. PALMX APPS LTD focuses on language learning and authentication apps, with less public review data available in the context of this collaboration. Fraunhofer AICOS itself is a research institution involved in various AI and human-centered design projects, including healthcare applications. There is limited information available on G2, Glassdoor, Capterra, or Reddit specifically combining all three entities, but Skin Analytics' product, DERM, has been positively reviewed in healthcare contexts. There are general discussions on Reddit about the reliability of reviews on platforms like G2 and Capterra, with some users expressing skepticism due to incentivized reviews.
Overall: MixedStrengths
- Skin Analytics' DERM AI tool boasts a 99.8% accuracy rate in ruling out skin cancer, surpassing dermatologists' 98.9% accuracy.
- The DERM tool provides quick assessments, with scans taking less than 30 seconds.
- DERM has received the first regulatory approval for AI to independently make clinical decisions on skin cancer without human oversight.
- The technology is being integrated into NHS pathways, helping to reduce backlogs and free up dermatology capacity.
- Fraunhofer AICOS is involved in various innovative projects, including those focused on human-centered design and AI in healthcare.
- PALMX APPS LTD develops engaging language learning apps and a secure palm-based authentication solution.
Limitations
- There is a lack of combined reviews for all three entities (Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics) on major review platforms like G2, Glassdoor, and Capterra.
- Some Reddit discussions indicate skepticism about the authenticity of reviews on platforms like G2 and Capterra due to incentivized review practices.
- There are general concerns on Reddit about the reliability and potential bias of reviews on major software review platforms.
- One Reddit user reported consistently receiving generic rejection emails from Fraunhofer-Gesellschaft, indicating a lack of personalized feedback for job applicants.
- A Reddit discussion about an AI startup in Germany (not directly identified as one of the named companies, but relevant to the AI field) highlighted concerns about inexperienced higher management and delivery issues.
- The PalmX app by Redrock Biometrics (which shares a similar name with PALMX APPS LTD) has not received enough ratings or reviews to display an overview on the App Store.
Based on reviews from: Evening Standard, FeaturedCustomers, App Store - Apple, Google Play, Skin Analytics Spa, palmx apps ltd, Fraunhofer-Gesellschaft, Reddit, YouTube
Last updated: 2026-09-13
Videos
News, demos, and interviews about Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics.
Videos load interactively. If none appear, search YouTube for Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics →
Press & Coverage
Frequently Asked Questions
Related Companies
The German Cancer Research Center (DKFZ) is the largest biomedical research institution in Germany and a leading international center for cancer research. Established in 1964, DKFZ is a member of the Helmholtz Association of German Research Centres. The center is dedicated to unraveling the causes and mechanisms of cancer development, identifying risk factors, and developing […]
aisencia GmbH is a healthcare AI company focused on revolutionizing diagnostic workflows in dermatopathology through artificial intelligence. They develop digital, AI-powered software solutions like Vistaneos and Cutaneos 80, designed to streamline pathology processes for faster, more precise, and accessible cancer diagnoses. The company’s technology aims to classify over 50 types of skin lesions, covering approximately […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
AI Agent, specifically referring to the platform accessible via https://vertexaisearch.cloud.google.com, is now known as the Gemini Enterprise Agent Platform. This platform is Google Cloud’s comprehensive and open solution for building, deploying, scaling, governing, and optimizing production-grade AI agents. It provides a unified environment that integrates machine learning models, such as generative AI agents and search […]
The German Research Center for Artificial Intelligence (DFKI) is a leading research institution in Germany, established in 1988 as a non-profit public-private partnership. It focuses on intelligent software technologies, combining scientific excellence with societal relevance. DFKI conducts application-oriented basic research to develop product functions, prototypes, and patentable solutions in information and communication technology. The center’s […]
Skin Analytics is a British health technology company that specializes in AI-powered solutions for skin cancer detection and diagnosis. Their flagship product, DERM, is an autonomous AI system designed to analyze images of skin lesions, triage patients, and potentially reduce waiting times for skin cancer assessments. DERM has achieved significant regulatory milestones, including a UKCA […]